When should serum tryptase be measured and what levels indicate acute mast‑cell activation versus systemic mastocytosis?

Serum Tryptase Measurement: Timing and Diagnostic Thresholds

Measure serum tryptase between 1-2 hours after symptom onset for acute mast cell activation, with optimal sampling up to 4 hours post-event, and use the consensus formula (20% increase above baseline plus 2 ng/mL) to distinguish acute activation from systemic mastocytosis. 1

When to Measure Serum Tryptase

Acute Mast Cell Activation (Anaphylaxis)

• Optimal timing: Draw serum tryptase 1-2 hours after symptom onset 1
• Acceptable window: Can be measured up to 4-6 hours after the event, though levels decline after peak 1, 2, 3
• Peak timing: Tryptase levels peak at approximately 1-1.5 hours after anaphylaxis onset 1, 3
• Half-life consideration: Tryptase has a 2-hour half-life in circulation, causing rapid decline after the acute event 3

Serial Sampling Protocol

Three-sample approach for comprehensive evaluation: 3

1. Initial sample: As soon as feasible during or immediately after resuscitation (do not delay treatment)
2. Peak sample: 1-2 hours after symptom onset
3. Baseline sample: Either at 24 hours or during convalescence (weeks later) to establish individual baseline

Critical caveat: IV fluid resuscitation dilutes blood and artificially lowers measured tryptase concentrations—this must be factored into interpretation 3

Diagnostic Thresholds and Interpretation

The Consensus Formula for Acute Mast Cell Activation

Diagnostic criterion: Peak tryptase must exceed baseline × 1.2 + 2 ng/mL (or 20% above baseline plus 2 ng/mL) 4, 5, 6

This formula has been validated with:

• Sensitivity: 78%
• Specificity: 91%
• Positive predictive value: 98%
• Negative predictive value: 44% 7

Important limitation: A normal tryptase level does not rule out anaphylaxis, as some reactions involve basophil or complement activation without mast cell tryptase release 3

Systemic Mastocytosis Criteria

Baseline tryptase >20 ng/mL serves as a minor diagnostic criterion for systemic mastocytosis 8, 9

• Normal range: 1-15 ng/mL (manufacturer upper limit is 11.4 ng/mL, but expert consensus extends to 15 ng/mL) 9
• Elevated baseline indicates increased mast cell burden from constitutive α-tryptase secretion 1, 3

Distinguishing Systemic Mastocytosis from Isolated Anaphylaxis

Tryptase ratio method (when α and β forms are measured separately): 1

• Ratio of total tryptase (α+β) to β-tryptase ≤10: Indicates anaphylaxis without systemic mastocytosis
• Ratio ≥20: Consistent with systemic mastocytosis

Mechanistic explanation:

• α-tryptase: Secreted constitutively; elevated in mastocytosis due to increased mast cell burden 1, 3
• β-tryptase: Released only during degranulation episodes; elevated in both anaphylaxis and mastocytosis during acute events 1, 3

Mast Cell Activation Syndrome (MCAS) Diagnosis

Required criteria (all three must be met): 5, 6

1. Typical clinical signs of recurrent, episodic, systemic mast cell activation involving ≥2 organ systems
2. Tryptase increase >20% + 2 ng/mL within 1-4 hours of symptom onset
3. Response to antimediator therapy

Baseline tryptase >8 ng/mL may suggest hereditary alpha tryptasemia, a genetic trait with increased TPSAB1 copy number 9

Common Pitfalls and Caveats

Timing Errors

• Too early (<15 minutes): Tryptase may not have peaked yet 2
• Too late (>6 hours): Levels may have returned to baseline, missing the diagnostic window 1

False Elevations (Non-Anaphylactic)

Elevated tryptase can occur in: 9, 10

• Chronic kidney disease
• Obesity
• Hematological neoplasms
• Postmortem samples (non-specific finding) 1, 3

Sensitivity Limitations

• Anaphylaxis without tryptase elevation occurs when basophils or complement (rather than mast cells) drive the reaction 3
• The assay has high specificity but relatively low sensitivity—some true anaphylaxis cases are missed 3

Interpretation Without Baseline

• Change from baseline is more diagnostically useful than absolute values due to wide inter-individual variation 3
• If baseline is unavailable, use the consensus formula with an assumed normal baseline of 5 ng/mL, but recognize this reduces diagnostic accuracy 9

Alternative and Complementary Biomarkers

When tryptase is equivocal or unavailable: 1, 2, 5

• Plasma histamine: Peaks at 5-10 minutes, elevated for only 30-60 minutes (impractical if patient seen >1 hour post-event)
• 24-hour urinary histamine metabolites: Elevated up to 24 hours post-event
• Urinary LTE₄ (leukotriene E4): Peaks in 0-3 hours, useful for up to 6 hours
• 11β-PGF₂α (prostaglandin metabolite): Correlates with anaphylaxis severity